UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2017-10, Vol.35 (30), p.3484-3515

2017

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1608-1632

2020

Volltextzugriff (PDF)

Maintenance Chemotherapy for Advanced Non–Small-Cell Lung Cancer: New Life for an Old Idea

Journal of clinical oncology, 2013-03, Vol.31 (8), p.1009-1020

2013

Volltextzugriff (PDF)

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3488-3515

2015

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

Journal of clinical oncology, 2022-10, Vol.40 (28), p.3323-3343

2022

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6251-6266

2009

Volltextzugriff (PDF)

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3307-3315

2011

Volltextzugriff (PDF)

Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study

Clinical cancer research, 2008-03, Vol.14 (5), p.1407-1412

2008

Volltextzugriff (PDF)

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3825-3831

2011

Volltextzugriff (PDF)

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599

Journal of clinical oncology, 2010-02, Vol.28 (6), p.949-954

2010

Volltextzugriff (PDF)

New molecularly targeted therapies for lung cancer

The Journal of clinical investigation, 2007-10, Vol.117 (10), p.2740-2750

2007

Volltextzugriff (PDF)

Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-02, Vol.27 (4), p.591-598

2009

Volltextzugriff (PDF)

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

Journal of clinical oncology, 2008-01, Vol.26 (1), p.60-65

2008

Volltextzugriff (PDF)

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors

Clinical cancer research, 2011-06, Vol.17 (11), p.3841-3849

2011

Volltextzugriff (PDF)

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

The New England journal of medicine, 2002-01, Vol.346 (2), p.92-98

2002

Volltextzugriff (PDF)

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Journal of clinical oncology, 2004-03, Vol.22 (5), p.777-784

2004

Volltextzugriff (PDF)

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Journal of clinical oncology, 2004-03, Vol.22 (5), p.785-794

2004

Volltextzugriff (PDF)

Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501

Journal of clinical oncology, 2009-12, Vol.27 (35), p.6006-6011

2009

Volltextzugriff (PDF)

Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1405-1412

2009

Volltextzugriff (PDF)

Efficacy and Safety of Axitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Phase II Study

Journal of clinical oncology, 2009-08, Vol.27 (23), p.3836-3841

2009

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-07, Vol.29 (19), p.2667-2674

2011

Volltextzugriff (PDF)

Attitudes and Stereotypes in Lung Cancer versus Breast Cancer

PloS one, 2015-12, Vol.10 (12), p.e0145715-e0145715

2015

Volltextzugriff (PDF)

A New Standard of Care for Advanced Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (22), p.2135-2137

Schiller, Joan H

2018

Volltextzugriff (PDF)

Randomized Phase III Study of Thoracic Radiation in Combination With Paclitaxel and Carboplatin With or Without Thalidomide in Patients With Stage III Non–Small-Cell Lung Cancer: The ECOG 3598 Study

Journal of clinical oncology, 2012-02, Vol.30 (6), p.616-622

2012

Volltextzugriff (PDF)

Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group Data

Journal of clinical oncology, 2005-01, Vol.23 (1), p.175-183

2005

Volltextzugriff (PDF)

1 – 25 von 399

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(372)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(181)
Science & Technology
(180)
Life Sciences & Biomedicine
(178)
Oncology
(161)
Female
(110)
Male
(105)
Lung Neoplasms - Drug Therapy
(104)
Biological And Medical Sciences
(96)
Medical Sciences
(91)
Middle Aged
(86)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(83)
Aged
(82)
Lung Neoplasms - Pathology
(70)
Adult
(66)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(63)
Carcinoma, Non-Small-Cell Lung - Pathology
(55)
Clin Oncol
(51)
Pharmacology. Drug Treatments
(50)
Neoplasm Staging
(48)
Antineoplastic Agents
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(71)
Journal Of Thoracic Oncology
(28)
Clinical Cancer Research
(19)
Lung Cancer
(19)
Cancer
(15)
Clinical Lung Cancer
(12)
Oncology
(8)
The New England Journal Of Medicine
(7)
Journal Of Immunotherapy
(5)
Cancer Chemotherapy And Pharmacology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Maintenance Chemotherapy for Advanced Non–Small-Cell Lung Cancer: New Life for an Old Idea

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599

New molecularly targeted therapies for lung cancer

Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501

Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab

Efficacy and Safety of Axitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Phase II Study

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Attitudes and Stereotypes in Lung Cancer versus Breast Cancer

A New Standard of Care for Advanced Lung Cancer

Randomized Phase III Study of Thoracic Radiation in Combination With Paclitaxel and Carboplatin With or Without Thalidomide in Patients With Stage III Non–Small-Cell Lung Cancer: The ECOG 3598 Study

Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group Data

Suchergebnisse filtern